Patents by Inventor Jeong Eun Kwon

Jeong Eun Kwon has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12171797
    Abstract: The present invention relates to a composition which is for preventing and ameliorating or treating premenstrual syndrome symptoms, and includes: (a) a Chrysanthemum zawadskii extract; (b) a mixture of the Chrysanthemum zawadskii extract and a malt extract; or (c) a mixture of the Chrysanthemum zawadskii extract, the malt extract, and an aloe extract. Specifically, the present compositions effectively inhibit the secretion of prolactin from pituitary cells, which is a phenomenon that appears during premenstrual syndrome, thereby increasing the secretion of progesterone, which is reduced during the luteal phase of women, and can thus be advantageously used as a composition for preventing and ameliorating or treating women's premenstrual syndrome.
    Type: Grant
    Filed: September 3, 2019
    Date of Patent: December 24, 2024
    Assignee: GENENCELL INC.
    Inventors: Yong Joon Jeong, Se Chan Kang, Jeong Eun Kwon, Da Eun Lee
  • Publication number: 20240082331
    Abstract: The present invention relates to a composition for controlling anti-obesity activity, containing, as an active ingredient, a Moringa oleifera fermentation product prepared using a novel Monascus purpureus SL1 strain, wherein the Moringa oleifera fermentation product provided in the present invention remarkably inhibits the differentiation of adipocytes and the Moringa oleifera fermentation product of the present invention has anti-obesity effects that are remarkably superior to those of Moringa oleifera powder.
    Type: Application
    Filed: November 9, 2021
    Publication date: March 14, 2024
    Applicant: MBIOMETHERAPEUTICS CO., LTD.
    Inventors: Se Chan KANG, Jeong Eun KWON, Yeong Geun LEE
  • Publication number: 20230390352
    Abstract: The present invention relates to a composition comprising a Salvia miltiorrhiza extract for prevention and treatment of depression in menopausal women. The Salvia miltiorrhiza extract of the present invention is characterized by regulating the release of luteinizing hormone and follicle-stimulating hormone and increasing the release of serotonin and norepinephrine to prevent, alleviate, and treat the hormonal change and depression occurring after menopause. In addition, since the raw material is highly stable, the composition comprising a danshensu-containing Salvia miltiorrhiza extract as an active ingredient retains the efficacy during long-term storage and thus can be suitable for use as an industrial substance.
    Type: Application
    Filed: November 17, 2020
    Publication date: December 7, 2023
    Applicant: UNDBIO.CO.,LTD
    Inventors: Se-Chan KANG, Yang-Mi HER, Hee-Ju SUH, Jeong-Eun KWON
  • Publication number: 20230302069
    Abstract: Provided is a lactic acid bacteria composition that is stable under strong acid conditions caused by gastric acid, bile acid, or the like, and specifically, to a lactic acid bacteria composition containing a Lactobacillus paracasei strain and an amino acid as active ingredients. The lactic acid bacteria composition according to the present invention may survive even under strong acidic conditions caused by gastric acid or bile acid and reach the intestine alive, and thus defend against and attack harmful bacteria in the intestine, multiply, produce metabolites, and promote metabolite production, thereby activating the immune system.
    Type: Application
    Filed: July 22, 2021
    Publication date: September 28, 2023
    Inventors: Se Chan KANG, Min Woo HAN, Jeong Eun KWON
  • Publication number: 20220280583
    Abstract: The present invention relates to a composition which is for preventing and ameliorating or treating premenstrual syndrome symptoms, and includes: (a) a Chrysanthemum zawadskii extract; (b) a mixture of the Chrysanthemum zawadskii extract and a malt extract; or (c) a mixture of the Chrysanthemum zawadskii extract, the malt extract, and an aloe extract. Specifically, the present compositions effectively inhibit the secretion of prolactin from pituitary cells, which is a phenomenon that appears during premenstrual syndrome, thereby increasing the secretion of progesterone, which is reduced during the luteal phase of women, and can thus be advantageously used as a composition for preventing and ameliorating or treating women's premenstrual syndrome.
    Type: Application
    Filed: September 3, 2019
    Publication date: September 8, 2022
    Applicant: GENENCELL INC.
    Inventors: Yong Joon Jeong, Se Chan Kang, Jeong Eun Kwon, Da Eun Lee